https://investor.ironwoodpharma.com/press-releases/press-release-details/2012/Linaclotide-Receives-Positive-CHMP-Opinion-for-the-Treatment-of-IBS-C/default.aspx
Ironwood Pharmaceuticals is a leading gastrointestinal (GI) healthcare company on a mission to advance the treatment of GI diseases and redefine the standard of care for GI patients.
- September 21, 2012